Coeptis Therapeutics Holdings- Warrants (31/10/2025)'s current cash is $5.2M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest current cash for COEPW is $5.2M as of March 2026. That compares with $4.3M in the prior-year period — up 22.1% year over year. Investors often review this figure alongside Coeptis Therapeutics Holdings- Warrants (31/10/2025)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, COEPW's current cash moved from $4.3M to $5.2M — a 22.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Coeptis Therapeutics Holdings- Warrants (31/10/2025)'s operating scale or balance-sheet position.
A current cash figure of $5.2M for COEPW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting COEPW's current cash ($5.2M), review year-over-year change from $4.3M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.